CM
Conor McNamara RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
39
Avg Return
Past Year
Past Year
2.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
79.5%
Neutral
20.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Outperform
Upgraded
| $73 |
17%
upside
| 4 | +17% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
Outperform
Maintained
| $5 |
42%
upside
| 2 | -1.7% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $255 |
35%
upside
| 2 | +16% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $3 |
73%
upside
| 2 | -16% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Sector Perform
Maintained
| $46 |
27%
downside
| 1 | – |
–
| 7 Aug ‘25 2 months ago |
|
|
Outperform
Upgraded
| $87 |
21%
upside
| 5 | +6% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $17 |
12%
upside
| 4 | -6.4% |
0
%
| 4 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $126 |
27%
upside
| 5 | -5.5% |
0
%
| 1 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $409 |
27%
upside
| 5 | +1.7% |
0
%
| 1 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $204 |
32%
upside
| 3 | -0.38% |
0
%
| 30 Jul ‘25 2 months ago |
|
|
Outperform
Maintained
| $637 |
17%
upside
| 2 | +0.45% |
0
%
| 24 Apr ‘25 5 months ago |
|
|
Outperform
Reiterated
| $250 |
20%
upside
| 3 | -6.7% |
0
%
| 23 Apr ‘25 6 months ago |
|
|
Outperform
Maintained
| $61 |
110%
upside
| 1 | -27% |
0
%
| 13 Feb ‘25 8 months ago |
|